Literature DB >> 14624795

Characterisation of endogenous retrovirus in rodent cell lines used for production of biologicals.

A J Shepherd1, N J Wilson, K T Smith.   

Abstract

Rodent cells are used widely to manufacture recombinant proteins for pharmaceutical use in humans and animals. However, all rodent cell lines express endogenous retroviruses that require appropriate testing regimes for identification and characterisation. In this communication we report the results of transmission electron microscopy, reverse transcriptase assay and infectious virus assays for retrovirus in 185 manufacturer cell banks of mouse, rat or hamster origin. The results indicated considerable variability of retroviral expression levels by transmission electron microscopy and reverse transcriptase assay, but nevertheless characteristic features of each cell type were observed. Infectious retrovirus was detected in mouse myeloma and hybridoma cell lines, but not in cell lines of hamster or rat origin. There was no evidence of contamination of cell banks with exogenous retrovirus. The results of retroviral characterisation of the parental mouse cell lines NS0, NS-1 and Sp2/0Ag14 by the above assays were consistent with the results of the survey. Co-cultivation of the above parental mouse cell lines with mouse and human cell lines suggested that the ability to infect human cells was related to threshold susceptibility of cell types and the levels of expression of infectious xenotropic retrovirus by mouse cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624795     DOI: 10.1016/s1045-1056(03)00065-4

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  11 in total

1.  Application of methods for viral clearance in stem cell production.

Authors:  Fernando Cobo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-13       Impact factor: 2.416

Review 2.  Modern uses of electron microscopy for detection of viruses.

Authors:  Cynthia S Goldsmith; Sara E Miller
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

3.  Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study.

Authors:  Ruth Ladenstein; Silke Weixler; Bianca Baykan; Matthias Bleeke; Renate Kunert; Dietmar Katinger; Ingrid Pribill; Petra Glander; Steffen Bauer; Vito Pistoia; Jean Michon; Alberto Garaventa; Holger N Lode
Journal:  MAbs       Date:  2013-05-31       Impact factor: 5.857

4.  An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV.

Authors:  Eiji Sato; Rika A Furuta; Takayuki Miyazawa
Journal:  Retrovirology       Date:  2010-12-20       Impact factor: 4.602

5.  No evidence of murine leukemia virus-related viruses in live attenuated human vaccines.

Authors:  William M Switzer; Haoqiang Zheng; Graham Simmons; Yanchen Zhou; Shaohua Tang; Anupama Shankar; Beatrix Kapusinszky; Eric L Delwart; Walid Heneine
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

6.  Characterization and mutagenesis of Chinese hamster ovary cells endogenous retroviruses to inactivate viral particle release.

Authors:  Pierre-Olivier Duroy; Sandra Bosshard; Emanuel Schmid-Siegert; Samuel Neuenschwander; Ghislaine Arib; Philippe Lemercier; Jacqueline Masternak; Lucien Roesch; Flavien Buron; Pierre-Alain Girod; Ioannis Xenarios; Nicolas Mermod
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

Review 7.  Virus detection by transmission electron microscopy: Still useful for diagnosis and a plus for biosafety.

Authors:  Philippe Roingeard; Pierre-Ivan Raynal; Sébastien Eymieux; Emmanuelle Blanchard
Journal:  Rev Med Virol       Date:  2018-11-09       Impact factor: 6.989

8.  The Genomic Scrapheap Challenge; Extracting Relevant Data from Unmapped Whole Genome Sequencing Reads, Including Strain Specific Genomic Segments, in Rats.

Authors:  Robin H van der Weide; Marieke Simonis; Roel Hermsen; Pim Toonen; Edwin Cuppen; Joep de Ligt
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

9.  Plasmonic Enhancement of Selective Photonic Virus Inactivation.

Authors:  Mina Nazari; Min Xi; Sarah Lerch; M H Alizadeh; Chelsea Ettinger; Hisashi Akiyama; Christopher Gillespie; Suryaram Gummuluru; Shyamsunder Erramilli; Björn M Reinhard
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.996

Review 10.  From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.

Authors:  Norman C Peterson
Journal:  ILAR J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.